CD37 and B-cell chronic lymphocytic leukemia: CD37-coated immunoliposomes effectively delivered cytotoxic drug to cell lines and CLL B-cells, and specificity could be altered by using a dual targeting approach with an additional CD19 or CD20 antibody.